(R)-1-(4-Cyanophenyl)ethylamine, 95.0%, 1g

2-(3-Fluoro-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

(1S,3S,6R)-N,N-dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide, 97.0%, 5g

(S)-2-Amino-4-((((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(3-(dimethylamino)propyl)amino)butanoic acid 2,2,2-trifluoroacetic acid salt, 97%, 5mg

5,6-Diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione, 95.0%, 5g

4-Hydroxy-2-methylpyridine, 95.0%, 5g

alpha,alpha,alpha',alpha'-Tetramethyl-1,4-benzenedimethanol, 97.0%, 25g

2,5-Diamino-4,6-dihydroxypyrimidine Hydrochloride>98.0%(T)(HPLC)25g

5-Bromo-4-chloro-2-(methylthio)pyrimidine, 95.0%, 100g

ethyl 4-chloro-5H-pyrrolo[3,2-d]pyrimidine-6-carboxylate, 97.0%, 100mg

1-CHLORO-5-FLUOROISOQUINOLINE, 95.0%, 250mg

4-Methoxy-3-methylbenzyl chloride (stabilised with calcium carbonate), 98.0%, 5g

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.001 g, 420 g, BCE423-1S (W)